Lloyd Segal is the founder of Repare Therapeutics. Repare Therapeutics has raised $151M in total funding. Latest round: Series B. Based in Montreal, Canada.
Lloyd Segal is the CEO of Repare Therapeutics, a U.S.-Canadian biotech company founded by Versant Ventures. Repare Therapeutics focuses on developing synthetic lethality drugs, with plans to advance its ATR inhibitor RP-3500 into clinical trials and other drugs into preclinical development. The company has raised significant funding, including an $82.5 million Series B round and $68 million in Series A funding.
Full founder directory · Investor directory · Company funding database · Fundraising library